Biomarker for fatty liver disease

First Page		Document Content
Date: 2015-04-17 03:09:11 Steatohepatitis Fatty liver Non-alcoholic fatty liver disease Biomarker Cirrhosis Liver disease Liver biopsy Liver Medicine Hepatology Hepatitis		Biomarker for fatty liver disease Add to Reading List Source URL: medicalxpress.com Download Document from Source Website File Size: 74,28 KB Share Document on Facebook

	CLIF Consortium Protocol of the CLIF Acute-oN-ChrONic LIver Failure in Cirrhosis (CANONIC) Core Study Case Report Form DocID: 1v63p - View Document
	Evaluation and Management of the Surgical Patient with Cirrhosis: Understanding and Justifying the Risk Dr. Eternity D. Labio FPCP FPSG FPSDE DocID: 1uVgT - View Document
	INFECTIOUS COMPLICATIONS IN PATIENTS WITH CIRRHOSIS: WHAT SHALL WE DO? Jenny Lim Limquiaco, MD DocID: 1uMjX - View Document
	COMMENTARY High fructose corn syrup (HFCS) plays a dominant role in the pathogenesis of NAFLD-associated cirrhosis Selin Sahin MD, Metin Basaranoglu MD DocID: 1uioY - View Document
	日本消化器病学会肝硬変診療ガイドライン 2015（改訂第 2 版） Evidence-based Clinical Practice Guidelines for Liver Cirrhosis 2015（2nd Edition）日本消化器病学会肝硬変診療ガイド DocID: 1t4b3 - View Document